Shikari® (S-ATAV) Anti-Avelumab ELISA
AVE-QLS-BAV
Enzyme immunoassay for the qualitative determination of antibodies to Avelumab (Bavencio®) in serum and plasma.
This kit has been especially developed for the qualitative determination of antibodies to Avelumab in serum and plasma.
The Matriks Biotek® Antibody to avelumab (Bavencio®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to avelumab (Bavencio®) in serum and plasma. It is for professional use only.
All SHIKARI® ELISA kits are suitable for biosimilar work.
All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.
For technical inquiry, please contact techsupport@matriksbiotek.com
| Required Volume (µl) | 20 |
| Total Time (min) | 140 |
| Sample | Serum, plasma |
| Sample Number | 96 |
| Detection Limit (ng/mL) | + / - |
| Spike Recovery (%) | - |
| Shelf Life (year) | 1 |
| Assay type | Qualitative |
| Species Reactivity | Human |
| Storage conditions | Store at +4°C. Please refer to protocols. |
| Shipping conditions | At room temperature |
